Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
Qing Wang
Li-Juan Song
Zhi-Bin Ding
Zhi Chai
Jie-Zhong Yu
Bao-Guo Xiao
Cun-Gen Ma
Keywords：Alzheimer's diseasecell-based therapycentral nervous system cellsfasudilimmunocytesmultiple sclerosisParkinson's diseasepericytesRho kinase inhibitorRho-associated kinases
Publication Date：2022-12-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：9( 2623-2631 )